Weight loss in HIV-infected patients [9]

New England Journal of Medicine

Volumn 347, Issue 16, 2002, Pages 1287-1288

  García Benayas, Teresa ^a   Blanco, Francisco ^a   Soriano, Vincent ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; DIDANOSINE; INTERFERON; LACTIC ACID; NUCLEOSIDE ANALOG; RIBAVIRIN; STAVUDINE;

HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; LETTER; LYMPHOCYTE COUNT; MULTIPLE ORGAN FAILURE; PANCREATITIS; PRIORITY JOURNAL; VIRUS LOAD; WEIGHT REDUCTION;

EID: 0037126343     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200210173471623     Document Type: Letter

References (4)

1. Lafeuillade A, Hittinger G, Chadapaud S. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. Lancet 2001;357:280-1.
2. Mitochondrial toxic effects and ribavirin. Lancet 2001;357:1802-4.
3. Klein M, Campeol N, Lalonde R, Wainberg M. A highly synergistic triple antiviral combination with potential activity against both HIV and hepatitis C viruses. In: Abstracts of the Eighth Conference on Retroviruses and Opportunistic Infections, Chicago, February 4-8, 2001:135. abstract.
4. Hester J, Keiser P, Berggren R. Pancreatitis: an emerging complication of HCV treatment in HIV coinfected patients treated with ddl/d4T containing regimens. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, December 16-19, 2001. Washington, D.C.: American Society for Microbiology, 2001:261. abstract.